+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BREO Ellipta Drugs Market by Mechanism Of Action, Indication, End User - Global Forecast to 2030- Product Image
BREO Ellipta Drugs Market by Mechanism Of Action, Indication, End User - Global Forecast to 2030- Product Image
Sale

BREO Ellipta Drugs Market by Mechanism Of Action, Indication, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013737
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Sustained therapeutic innovation and evolving healthcare requirements continue to shape the BREO Ellipta Drugs Market, presenting senior decision-makers with both new challenges and significant opportunities. This executive overview provides the actionable context needed to make informed strategic decisions in a competitive and rapidly changing marketplace.

Market Snapshot: BREO Ellipta Drugs Market

The BREO Ellipta Drugs Market grew from USD 3.18 billion in 2024 to USD 3.33 billion in 2025. Sustained growth is projected, with a CAGR of 4.57%, reaching USD 4.16 billion by 2030. The market’s momentum stems from increased adoption of once-daily therapies that address chronic respiratory disorders, intensifying competition from emerging generics, and stakeholders’ focus on cost-effective healthcare delivery. As healthcare systems worldwide demand high-value interventions, market participants are navigating tariff impacts, shifts in regulatory frameworks, and technology integration.

Scope & Segmentation

  • Mechanism of Action: Includes inhaled corticosteroids (ICS), ICS/long-acting beta agonists (LABA), ICS/LAMA/LABA, LABA, LAMA, and dual LAMA/LABA pairings such as fluticasone furoate vilanterol and umeclidinium combinations.
  • Therapeutic Indication: Covers asthma, asthma-COPD overlap, and chronic obstructive pulmonary disease (COPD), supporting diverse patient segments and evolving disease management strategies.
  • End User Channels: Targeted at homecare, hospitals, and specialty clinics, enabling flexible adoption based on patient setting and provider capability.
  • Geographical Coverage: Encompasses three primary regions—Americas (including key US states such as California, Texas, New York, Florida, Illinois, Pennsylvania, and Ohio alongside Canada, Mexico, Brazil, and Argentina); Europe, Middle East & Africa (with focus on the United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and other key markets); and Asia-Pacific (covering major economies like China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, and Taiwan).
  • Leading Companies: Profiles GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Novartis AG, Chiesi Farmaceutici S.p.A., Teva Pharmaceutical Industries Ltd, Viatris Inc., Cipla Ltd, Sun Pharmaceutical Industries Ltd, and Lupin Limited.
  • Technology Integration: Examines advancements in digital inhaler sensors, adherence monitoring, and precision medicine initiatives within respiratory care.

Key Takeaways for Senior Leadership

  • Innovation in digital inhaler technologies is shifting competitive dynamics and providing new routes for real-time patient engagement.
  • Biosimilar and generic launches are redefining value-based contracting and driving the need for robust, outcomes-backed economic propositions.
  • Heightened attention to environmental impact is prompting investments into propellant-free delivery systems, influencing procurement and R&D priorities.
  • Regional reimbursement and adoption patterns mandate tailored go-to-market strategies to address diverse formulary and payer requirements.
  • Strategic partnerships—spanning device manufacturers and technology firms—are evolving the product ecosystem and contributing to improved care pathways.
  • Integration of homecare and specialty channels supports broader patient access and enhances long-term adherence outcomes.

2025 Tariff Impact Overview

Forthcoming United States tariffs in 2025 are expected to raise cost structures across inhalation therapies by increasing import duties on select excipients and specialized packaging. Companies are responding by diversifying sourcing, exploring nearshoring, and renegotiating supply agreements to control exposure. Payers and healthcare systems are seeking more rigorous value evidence to justify pricing shifts generated by these tariff changes. Commercial and procurement strategies are evolving accordingly, with implications for market share and partnership models across the supply chain.

Methodology & Data Sources

This report utilizes layered research, starting with secondary analysis of peer-reviewed sources and regulatory filings. Insights are further validated through interviews with pulmonologists, payers, and supply chain executives, along with proprietary survey data from key healthcare providers and pharmacy leaders. Analytical robustness is ensured through data triangulation and rigorous sensitivity testing. These steps collectively provide a credible foundation for strategic recommendations.

Why This Report Matters

  • Enables informed portfolio optimization and investment choices amid fast-evolving respiratory care trends.
  • Equips executive teams to anticipate operational and commercial impacts from regulatory, tariff, and technological changes.
  • Supports customized, actionable strategies for stakeholder engagement across regions and channels.

Conclusion

This resource offers practical and timely perspectives to guide leadership decisions as the BREO Ellipta Drugs Market transforms. Stay prepared for market shifts, and leverage evidence-based insights to strengthen your competitive position and deliver improved patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. BREO Ellipta Drugs Market, by Mechanism Of Action
8.1. Introduction
8.2. ICS
8.3. ICS/LABA
8.3.1. Fluticasone Furoate Vilanterol
8.4. ICS/LAMA/LABA
8.4.1. Fluticasone Furoate Umeclidinium Vilanterol
8.5. LABA
8.6. LAMA
8.6.1. Umeclidinium
8.7. LAMA/LABA
8.7.1. Umeclidinium Vilanterol
9. BREO Ellipta Drugs Market, by Indication
9.1. Introduction
9.2. Asthma
9.3. Asthma COPD Overlap
9.4. COPD
10. BREO Ellipta Drugs Market, by End User
10.1. Introduction
10.2. Homecare
10.3. Hospitals
10.4. Specialty Clinics
11. Americas BREO Ellipta Drugs Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa BREO Ellipta Drugs Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific BREO Ellipta Drugs Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. GlaxoSmithKline plc
14.3.2. AstraZeneca plc
14.3.3. Boehringer Ingelheim International GmbH
14.3.4. Novartis AG
14.3.5. Chiesi Farmaceutici S.p.A.
14.3.6. Teva Pharmaceutical Industries Ltd
14.3.7. Viatris Inc.
14.3.8. Cipla Ltd
14.3.9. Sun Pharmaceutical Industries Ltd
14.3.10. Lupin Limited
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BREO ELLIPTA DRUGS MARKET MULTI-CURRENCY
FIGURE 2. BREO ELLIPTA DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. BREO ELLIPTA DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BREO ELLIPTA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BREO ELLIPTA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BREO ELLIPTA DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY FLUTICASONE FUROATE VILANTEROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY FLUTICASONE FUROATE UMECLIDINIUM VILANTEROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LABA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY UMECLIDINIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY UMECLIDINIUM VILANTEROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ASTHMA COPD OVERLAP, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 46. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 47. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 48. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 49. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 50. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 56. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 57. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 89. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 90. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 91. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 92. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 93. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 96. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 97. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 98. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 99. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 100. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 103. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 104. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 110. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 111. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 112. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 113. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 114. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 117. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 118. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 119. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 120. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 121. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 124. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 125. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 131. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 132. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 138. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 139. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 145. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 146. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 147. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 148. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 149. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 152. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 153. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 159. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 160. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 161. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 162. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 163. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 166. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 167. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 168. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 169. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 170. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. EGYPT BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 187. EGYPT BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 188. EGYPT BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 189. EGYPT BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 190. EGYPT BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 191. EGYPT BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 192. EGYPT BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. TURKEY BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 194. TURKEY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 195. TURKEY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 196. TURKEY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 197. TURKEY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 198. TURKEY BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. TURKEY BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. ISRAEL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 201. ISRAEL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 202. ISRAEL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. NORWAY BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 208. NORWAY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 209. NORWAY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 210. NORWAY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 211. NORWAY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 212. NORWAY BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. POLAND BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 215. POLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 216. POLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 217. POLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 218. POLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 219. POLAND BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. POLAND BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 236. CHINA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 237. CHINA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 238. CHINA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 239. CHINA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 240. CHINA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 241. CHINA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 242. CHINA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. INDIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 244. INDIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 245. INDIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 246. INDIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 247. INDIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 248. INDIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 249. INDIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. JAPAN BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 251. JAPAN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 252. JAPAN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 253. JAPAN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 254. JAPAN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 255. JAPAN BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 256. JAPAN BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. THAILAND BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 279. THAILAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 280. THAILAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 281. THAILAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 282. THAILAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 283. THAILAND BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 284. THAILAND BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. MALAYSIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. SINGAPORE BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 300. SINGAPORE BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 301. SINGAPORE BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. VIETNAM BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 307. VIETNAM BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 308. VIETNAM BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. TAIWAN BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 314. TAIWAN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2030 (USD MILLION)
TABLE 315. TAIWAN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. BREO ELLIPTA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 321. BREO ELLIPTA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this BREO Ellipta Drugs market report include:
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Chiesi Farmaceutici S.p.A.
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Limited

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.33 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.16 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Image

TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • 30 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2025 - Product Image

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Image

ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • 30 Pages
  • Global
From
Respiratory Inhalers Market by Product Type, Drug Class, Distribution Channel, Indication, Patient Age Group - Global Forecast to 2030 - Product Image

Respiratory Inhalers Market by Product Type, Drug Class, Distribution Channel, Indication, Patient Age Group - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Treatment Market by Product Type, Drug Class, Route of Administration, Distribution Channel, Therapy Type - Global Forecast to 2030 - Product Image

Chronic Obstructive Pulmonary Disease Treatment Market by Product Type, Drug Class, Route of Administration, Distribution Channel, Therapy Type - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.